SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-337330
Filing Date
2017-11-08
Accepted
2017-11-08 16:33:15
Documents
4
Effectiveness Date
2017-11-08

Document Format Files

Seq Description Document Type Size
1 S-8 d487772ds8.htm S-8 43649
2 EX-5.1 d487772dex51.htm EX-5.1 22761
3 EX-23.1 d487772dex231.htm EX-23.1 1385
4 EX-23.2 d487772dex232.htm EX-23.2 1338
  Complete submission text file 0001193125-17-337330.txt   70102
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-221427 | Film No.: 171187047
SIC: 2836 Biological Products, (No Diagnostic Substances)